Search Results - "Lanciego, Jose Luis"
-
1
Prime time for G-protein-coupled receptor heteromers as therapeutic targets for CNS disorders: the dopamine D₁-D₃ receptor heteromer
Published in CNS & neurological disorders drug targets (01-11-2010)“…A number of G-protein-coupled receptors (GPCRs) are currently under consideration as potential therapeutic targets for drugs acting in the central nervous…”
Get more information
Journal Article -
2
Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims
Published in Neurotherapeutics (01-07-2018)“…Recent studies point to the cannabinoid CB 2 receptors (CB 2 r) and the non-cannabinoid receptor GPR55 as potential key targets involved in the response to…”
Get full text
Journal Article -
3
History and future challenges of the subthalamic nucleus as surgical target: Review article
Published in Movement disorders (01-10-2018)“…ABSTRACT For many years the subthalamic nucleus had a poor reputation among neurosurgeons as a result of the acute movement disorders that develop after its…”
Get full text
Journal Article -
4
Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease
Published in Pharmacology & therapeutics (Oxford) (01-12-2011)“…Several selective antagonists for adenosine A 2A receptors (A 2A R) are currently under evaluation in clinical trials (phases I to III) to treat Parkinson’s…”
Get full text
Journal Article -
5
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia
Published in Brain, behavior, and immunity (01-01-2018)“…•LPS plus interferon-γ upregulate CB2 receptors in microglia.•LPS plus interferon-γ upregulate CB1-CB2 receptor complexes in microglia.•ß amyloid and LPS plus…”
Get full text
Journal Article -
6
Cx3cr1‐deficiency exacerbates alpha‐synuclein‐A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease
Published in Glia (01-08-2018)“…Parkinson's disease (PD) is the second most common neurodegenerative disorder characterized by the degeneration of dopaminergic neurons of the substantia nigra…”
Get full text
Journal Article -
7
Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys
Published in Biomaterials (01-12-2016)“…Abstract Glial cell line-derived neurotrophic factor (GDNF) remains the most potent neurotrophic factor for dopamine neurons. Despite its potential as…”
Get full text
Journal Article -
8
Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain
Published in The Journal of biological chemistry (15-06-2012)“…Exploring the role of cannabinoid CB2 receptors in the brain, we present evidence of CB2 receptor molecular and functional interaction with cannabinoid CB1…”
Get full text
Journal Article -
9
Tadalafil crosses the blood–brain barrier and reverses cognitive dysfunction in a mouse model of AD
Published in Neuropharmacology (01-01-2013)“…Previous studies have demonstrated that cognitive function can be restored in mouse models of Alzheimer's disease (AD) following administration of sildenafil,…”
Get full text
Journal Article -
10
The cellular prion protein does not affect tau seeding and spreading of sarkosyl-insoluble fractions from Alzheimer’s disease
Published in Scientific reports (16-09-2024)“…The cellular prion protein (PrP C ) plays many roles in the developing and adult brain. In addition, PrP C binds to several amyloids in oligomeric and…”
Get full text
Journal Article -
11
Adeno-Associated Viral Vectors as Versatile Tools for Parkinson’s Research, Both for Disease Modeling Purposes and for Therapeutic Uses
Published in International journal of molecular sciences (15-06-2021)“…It is without any doubt that precision medicine therapeutic strategies targeting neurodegenerative disorders are currently witnessing the spectacular rise of…”
Get full text
Journal Article -
12
Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of Parkinson's disease
Published in Movement disorders (15-08-2011)“…Background: Glial cell‐derived neurotrophic factor is a survival factor for dopaminergic neurons and a promising candidate for the treatment of Parkinson's…”
Get full text
Journal Article -
13
Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment
Published in Life (Basel, Switzerland) (01-11-2022)“…Rare diseases, especially monogenic diseases, which usually affect a single target protein, have attracted growing interest in drug research by encouraging…”
Get full text
Journal Article -
14
GPR40 activation leads to CREB and ERK phosphorylation in primary cultures of neurons from the mouse CNS and in human neuroblastoma cells
Published in Hippocampus (01-07-2014)“…ABSTRACT GPR40, the free fatty acid receptor 1, is expressed strongly in the primate pancreas and brain. While the role of pancreatic GPR40 in glucose…”
Get full text
Journal Article -
15
Adeno-Associated Viral Vectors as Versatile Tools for Neurological Disorders: Focus on Delivery Routes and Therapeutic Perspectives
Published in Biomedicines (23-03-2022)“…It is without doubt that the gene therapy field is currently in the spotlight for the development of new therapeutics targeting unmet medical needs. Thus,…”
Get full text
Journal Article -
16
Interactions between Calmodulin, Adenosine A2A, and Dopamine D2 Receptors
Published in The Journal of biological chemistry (09-10-2009)“…The Ca2+-binding protein calmodulin (CaM) has been shown to bind directly to cytoplasmic domains of some G protein-coupled receptors, including the dopamine D2…”
Get full text
Journal Article -
17
Adeno-associated virus liver transduction efficiency measured by in vivo [18F]FHBG positron emission tomography imaging in rodents and nonhuman primates
Published in Human gene therapy (01-08-2011)“…Recombinant adeno-associated virus 5 (rAAV5) represents a candidate vector with unique advantages for the treatment of hepatic disorders because of its narrow…”
Get more information
Journal Article -
18
Two types of periglomerular cells in the olfactory bulb of the macaque monkey (Macaca fascicularis)
Published in Brain Structure and Function (01-07-2013)“…The olfactory bulb (OB) of mammals is the brain region that receives the sensory information coming from the olfactory epithelium. The entrance of the…”
Get full text
Journal Article -
19
Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease
Published in Molecular neurobiology (01-08-2019)“…Cannabinoid CB 1 receptors (CB 1 R) and the GPR55 receptor are expressed in striatum and are potential targets in the therapy of Parkinson’s disease (PD), one…”
Get full text
Journal Article -
20
Boolean analysis shows a high proportion of dopamine D2 receptors interacting with adenosine A2A receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease
Published in Neurobiology of disease (01-11-2023)“…The antagonistic effect of adenosine on dopaminergic transmission in the basal ganglia indirect motor control pathway is mediated by dopamine D2 (D2R) and…”
Get full text
Journal Article